GABRG2 rs987525: Understanding Your Genetic Variant
The rs987525 variant is a common genetic change located within the GABRG2 gene. It has been studied for its potential association with a predisposition to febrile seizures and various epilepsy syndromes.
What each genotype means
Typical genetic profile
This genotype represents the most common genetic sequence observed in the general population for this location. It is not considered a risk factor for the epilepsy syndromes associated with rare, pathogenic variants in the GABRG2 gene. Having this genotype does not rule out the possibility of developing seizures due to other genetic or environmental factors.
This is the most common genotype found across all major global populations.
Typical genetic profile
This genotype is commonly observed and is not typically associated with the rare, pathogenic mutations in GABRG2 that are linked to epilepsy or febrile seizures. Research indicates that the GABRG2 gene is associated with a spectrum of seizure disorders, but these are generally linked to specific, rare variants rather than this common sequence variation. You should consult with a healthcare provider if you have concerns regarding personal or family history of seizures.
This genotype is frequently observed in diverse populations worldwide.
Typical genetic profile
This genotype is a common variation and is not identified as a pathogenic mutation linked to GABRG2-related epilepsy syndromes. While GABRG2 variants are known to contribute to a range of conditions from febrile seizures to more severe epilepsy, this specific genotype is considered part of the normal range of human genetic diversity. Always discuss any neurological symptoms or family history of epilepsy with a qualified medical professional.
This genotype is common and found at varying frequencies across different ancestral groups.
What is the rs987525 Variant?
The rs987525 variant is a single nucleotide polymorphism (SNP) located within the GABRG2 gene. In genetics, a SNP represents a variation at a single position in the DNA sequence among individuals. This specific variant is found in a region of the genome that codes for the gamma-aminobutyric acid type A (GABA-A) receptor, a critical component of the brain's inhibitory signaling system. Because this variant is common in the general population, researchers often study it to understand how subtle differences in our genetic code might influence neurological health. It is important to note that the presence of a common SNP does not automatically imply a medical condition; rather, it is a piece of data that researchers use to investigate statistical links between specific genetic markers and health outcomes like seizure susceptibility.
The Role of the GABRG2 Gene
The GABRG2 gene provides instructions for making a protein that acts as a subunit for the GABA-A receptor. These receptors are essential for normal brain function because they help regulate the excitability of neurons. When GABA binds to these receptors, it typically produces an inhibitory effect, which helps prevent the brain from becoming overstimulated. Mutations or variations in GABRG2 can potentially alter the structure or function of these receptors, which may lead to an imbalance in brain signaling. Research has shown that significant mutations in this gene are linked to a spectrum of conditions, ranging from simple febrile seizures—seizures triggered by fever in children—to more complex epilepsy syndromes. Understanding how GABRG2 functions helps scientists map the biological pathways that contribute to seizure disorders.
Research and Evidence Strength
The association between GABRG2 variants and epilepsy is well-documented in scientific literature, though the evidence strength for any single SNP like rs987525 varies. While specific pathogenic mutations in GABRG2 are known to cause familial epilepsy syndromes, the clinical significance of common SNPs is often more complex. Current research suggests that while some variants may contribute to a genetic predisposition, they often act in combination with other genetic and environmental factors. The evidence for rs987525 is considered moderate, meaning that while studies have identified statistical associations, it is not a definitive diagnostic marker for epilepsy. Because epilepsy is a heterogeneous condition, the impact of this variant can differ significantly between individuals. Researchers continue to use large-scale genomic studies to clarify how these common variants influence the risk of developing seizure-related conditions.
Population Frequency
The rs987525 variant is classified as a common SNP, meaning it appears frequently across diverse human populations. Because it is common, many individuals carry this variant without experiencing any neurological symptoms or seizure disorders. Its prevalence highlights that genetic variation is a normal part of human biology. When researchers analyze population data, they look for differences in frequency between groups with and without specific health conditions to determine if a variant might be a contributing factor. However, because this variant is widespread, it is rarely used in isolation to predict health outcomes. Its presence in the general population underscores the importance of considering the broader genetic context, as well as environmental influences, when evaluating the risk of complex conditions like epilepsy.
What You Can Do With This Information
Information about genetic variants like rs987525 is primarily intended for educational purposes and to foster a better understanding of your genetic makeup. It is crucial to understand that this information is not a medical diagnosis and cannot predict whether you will develop a seizure disorder. If you have concerns about your health, family history of seizures, or neurological symptoms, the most important step is to consult with a qualified healthcare professional, such as a neurologist or a genetic counselor. They can provide context based on your personal medical history and clinical presentation. Never use genetic data to make decisions about medications or treatments without professional guidance. If you are currently taking medication for a seizure-related condition, always discuss any questions regarding your dosage or treatment plan with your clinician or pharmacist.
How common is this variant?
The rs987525 variant is common across most global populations, with its specific genotype frequencies varying slightly by ancestry.
Frequently asked questions
Does having the rs987525 variant mean I have epilepsy?
No. This variant is a common genetic marker and is not a diagnostic test for epilepsy. Many people carry this variant without ever experiencing seizures or any neurological condition.
Can I use this information to change my medication?
Absolutely not. You should never change your medication or dosage based on genetic test results. Always consult your doctor or pharmacist before making any changes to your prescribed treatment.
Is GABRG2-related epilepsy inherited?
Some pathogenic mutations in the GABRG2 gene are inherited in an autosomal dominant pattern. However, common SNPs like rs987525 do not follow this simple inheritance pattern and are not considered direct causes of disease.
Where can I find more information about my specific genetic results?
If you have received genetic testing results, the best resource is a genetic counselor or your primary care physician. They can help interpret your results within the context of your personal and family health history.
Sources & further reading
Educational information only, last refreshed 9/26/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs987525?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in GABRG2
This variant in the GABRG2 gene is associated with variations in response to certain anticonvulsant medications and epilepsy susceptibility.
This variant is located in the GABRG2 gene, which encodes the gamma-2 subunit of the GABA-A receptor; variants in this gene are associated with a spectrum of epilepsy syndromes.
Linked to GABA-A receptor subunit dysfunction, a known mechanism for inherited epilepsy syndromes.
A common variant in GABRG2, a gene encoding a GABA-A receptor subunit linked to various epilepsy phenotypes including febrile seizures and GEFS+.
Variant in GABRG2, a gene where mutations can alter GABA-A receptor function and influence seizure thresholds.
Mutations in GABRG2 are linked to a spectrum of epilepsy ranging from simple febrile seizures to severe developmental and epileptic encephalopathies.